盛屯礦業(600711.SH)擬0港元受讓香港科立鑫100%股權
格隆匯12月2日丨盛屯礦業(600711.SH)公佈,公司擬以全資子公司科立鑫國際貿易有限公司(以下簡稱“科立鑫貿易”)受讓香港科立鑫金屬材料有限公司(以下簡稱“香港科立鑫”)100%股權。本次交易完成後,香港科立鑫成為公司的全資子公司。
2019年10月31日的淨資產為-66.65萬港元。香港科立鑫實控人林奮生保證,在本次股權交割前以其對香港科立鑫66.65萬港元的債權對香港科立鑫進行增資,增資後香港科立鑫註冊資本為66.65萬港元。雙方協商確定,本次的交易價格為0港元。
鑑於香港科立鑫的控制人林奮生為公司持股5%以上的股東,根據《上海證券交易所股票上市規則》,本次交易屬於關聯交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.